Casdin Partners Master Fund, L.p.

Affiliations

  • Large Shareholder at Biolife Solutions Inc (BLFS), 2025-06-13
  • Director at 2Seventy Bio Inc. (TSVT), 2025-05-15
  • Large Shareholder, Director at Standard Biotools Inc. (LAB), 2025-03-05
  • Large Shareholder, Director at Genedx Holdings Corp. (WGS), 2024-08-05
  • Large Shareholder at Maxcyte Inc. (MXCT), 2022-10-05
  • Large Shareholder at Tenaya Therapeutics Inc. (TNYA), 2021-08-04
  • Director at Absci Corp (ABSI), 2021-07-28
  • Large Shareholder at Verve Therapeutics Inc. (VERV), 2021-06-22
  • Large Shareholder at Decibel Therapeutics Inc. (DBTX), 2021-02-19
  • Large Shareholder at Fulcrum Therapeutics Inc. (FULC), 2019-07-22
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2018-07-24
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LAB $1.07 4,820,959 $5,134,321.34 58,846,780 2025-02-28 Filing
LAB $2.19 250,000 $546,750.00 54,025,821 2024-08-27 Filing
LAB $2.15 150,000 $322,455.00 53,775,821 2024-08-26 Filing
LAB $2.13 292,100 $620,975.39 53,625,821 2024-08-23 Filing
LAB $1.96 307,900 $602,806.62 53,333,721 2024-08-22 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BLFS $23.80 1,000,000 $23,800,000.00 7,707,165 2025-06-10 Filing
MXCT $6.15 735,786 $4,525,083.90 10,000,000 2022-10-03 Filing
MXCT $4.30 3,235,548 $13,912,856.40 10,735,786 2022-07-01 Filing